Corcept Therapeutics Inc’s recently made public that its insider Maduck Sean unloaded Company’s shares for reported $0.43 million on Mar 18 ’24. In the deal valued at $25.00 per share,17,219 shares were sold. As a result of this transaction, Maduck Sean now holds 75,222 shares worth roughly $1.84 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Swisher Daniel N JR sold 2,200 shares, generating $51,898 in total proceeds. Upon selling the shares at $23.59, the Director now owns 0 shares.
Before that, Maduck Sean sold 27,068 shares. Corcept Therapeutics Inc shares valued at $702,905 were divested by the insider at a price of $25.97 per share. As a result of the transaction, Maduck Sean now holds 74,455 shares, worth roughly $1.82 million.
Truist upgraded its Corcept Therapeutics Inc [CORT] rating to a Buy from a a Hold in a research note published on November 06, 2023; the price target was increased to $38 from $29. A number of analysts have revised their coverage, including SVB Securities’s analysts, who began to cover the stock in mid April with a ‘”a Market perform”‘ rating. Piper Sandler began covering CORT with “an Overweight” recommendation on April 04, 2023. Jefferies revised its rating on February 15, 2023. It rated CORT as “a Hold” which previously was an “a Buy”.
Price Performance Review of CORT
On Friday, Corcept Therapeutics Inc [NASDAQ:CORT] saw its stock fall -1.01% to $24.50. Over the last five days, the stock has gained 5.47%. Corcept Therapeutics Inc shares have fallen nearly -24.57% since the year began. Nevertheless, the stocks have risen 17.56% over the past one year. While a 52-week high of $34.28 was reached on 01/08/24, a 52-week low of $20.84 was recorded on 02/02/24. SMA at 50 days reached $23.30, while 200 days put it at $26.40. A total of 0.74 million shares were traded, compared to the trading of 0.77 million shares in the previous session.
Levels Of Support And Resistance For CORT Stock
The 24-hour chart illustrates a support level at 24.19, which if violated will result in even more drops to 23.89. On the upside, there is a resistance level at 24.84. A further resistance level may holdings at 25.19. The Relative Strength Index (RSI) on the 14-day chart is 55.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.64, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 21.37%. Stochastics %K at 80.91% indicates the stock is a selling.
How much short interest is there in Corcept Therapeutics Inc?
A steep rise in short interest was recorded in Corcept Therapeutics Inc stocks on Feb 29, 2024, growing by 0.54 million shares to a total of 19.86 million shares. Yahoo Finance data shows the prior-month short interest on Jan 31, 2024 was 19.32 million shares. There was a rise of 2.72%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 30.82% of the overall stock float, the days-to-cover ratio (short ratio) rose to 13.63.
